1. Home
  2. SPRO vs PEW Comparison

SPRO vs PEW Comparison

Compare SPRO & PEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Logo GrabAGun Digital Holdings Inc.

PEW

GrabAGun Digital Holdings Inc.

HOLD

Current Price

$2.15

Market Cap

72.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
PEW
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
72.6M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
SPRO
PEW
Price
$1.24
$2.15
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $6.75
AVG Volume (30 Days)
★ 711.7K
182.8K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 111.81
N/A
EPS
N/A
★ N/A
Revenue
$66,802,000.00
★ $96,449,000.00
Revenue This Year
N/A
$5.25
Revenue Next Year
$300.00
$7.96
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 39.24
3.57
52 Week Low
$1.08
$2.06
52 Week High
$3.08
$5.23

Technical Indicators

Market Signals
Indicator
SPRO
PEW
Relative Strength Index (RSI) 50.69 36.66
Support Level $1.10 $2.06
Resistance Level $1.27 $2.40
Average True Range (ATR) 0.06 0.08
MACD 0.02 0.00
Stochastic Oscillator 38.24 26.47

Price Performance

Historical Comparison
SPRO
PEW

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About PEW GrabAGun Digital Holdings Inc.

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.

Share on Social Networks: